Damyang-gun Provides Year-Round Medical Expense Support for Cancer Patients

[Damyang=Asia Economy Honam Reporting Headquarters Reporter Kim Chunsu] On the 15th, Damyang-gun, Jeollanam-do announced that it will carry out a year-round medical expense support project to alleviate the economic burden of cancer patients.

The medical expense support targets cancer patients who are health insurance subscribers diagnosed with stomach cancer, liver cancer, colorectal cancer, breast cancer, cervical cancer, or lung cancer, which are covered by the national cancer screening program.

From January 2021, if the health insurance premium is 103,000 KRW or less for workplace subscribers and 97,000 KRW or less for regional subscribers, the insured can receive support for their out-of-pocket medical expenses up to 2 million KRW per year.

Medical aid recipients are supported for all cancers with an annual limit of 1.2 million KRW for insured out-of-pocket expenses and 1 million KRW for uninsured out-of-pocket expenses. Both health insurance subscribers and medical aid recipients can receive support for up to three consecutive years if they meet the criteria each year.

For pediatric cancer patients, medical aid recipients are automatically eligible, and among health insurance subscribers, those who meet income and property criteria are selected to receive support for all cancers up to 20 million KRW annually until the age of 18.

A county official stated, “Health insurance subscribers must undergo the national cancer screening to be eligible for medical expense support, so we urge eligible individuals to make sure to receive the national cancer screening.”

Meanwhile, this year’s national cancer screening targets are those born in odd-numbered years, and medical aid recipients and health insurance subscribers in the lower 50% income bracket can receive free screenings for the six major cancers (stomach, liver, colorectal, breast, cervical, and lung cancer).

This content was produced with the assistance of AI translation services.